Nektar Therapeutics (NKTR) Insider Trading
- $1,135,850.00
- $232,426,187.16
- May 10, 2024
- Howard W Robin
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Aug. 1, 2016 | Director | 5,000 | $17.26 | Sell | $86,300.00 | |
July 11, 2016 | CAO | 100,000 | $15.09 | Sell | $1,509,000.00 | |
July 1, 2016 | Director | 5,000 | $14.10 | Sell | $70,500.00 | |
May 17, 2016 | SVP | 836 | $13.58 | Sell | $11,352.88 | |
May 17, 2016 | CEO | 2,170 | $13.58 | Sell | $29,468.60 | |
May 17, 2016 | CAO | 724 | $13.58 | Sell | $9,831.92 | |
May 17, 2016 | CFO | 856 | $13.58 | Sell | $11,624.48 | |
April 25, 2016 | Director | 15,000 | $16.27 | Sell | $244,050.00 | |
Feb. 17, 2016 | CEO | 2,147 | $11.92 | Sell | $25,592.24 | |
Feb. 17, 2016 | CAO | 716 | $11.92 | Sell | $8,534.72 | |
Feb. 17, 2016 | SVP | 963 | $11.92 | Sell | $11,478.96 | |
Feb. 10, 2016 | CAO | 15,000 | $11.49 | Sell | $172,350.00 | |
Feb. 10, 2016 | CEO | 66,666 | $11.49 | Sell | $765,992.34 | |
Feb. 10, 2016 | SVP | 11,666 | $11.49 | Sell | $134,042.34 | |
Jan. 20, 2016 | Director | 15,000 | $14.51 | Sell | $217,650.00 | |
Jan. 19, 2016 | SVP | 11,667 | $14.12 | Sell | $164,738.04 | |
Jan. 19, 2016 | CEO | 66,667 | $14.12 | Sell | $941,338.04 | |
Jan. 19, 2016 | CAO | 15,000 | $14.12 | Sell | $211,800.00 | |
Dec. 4, 2015 | Director | 15,000 | $15.82 | Sell | $237,300.00 | |
Dec. 3, 2015 | SVP | 45,001 | $15.87 | Sell | $714,165.87 | |
Dec. 3, 2015 | CEO | 125,001 | $15.87 | Sell | $1,983,765.87 | |
Dec. 3, 2015 | CAO | 15,000 | $15.87 | Sell | $238,050.00 | |
Nov. 20, 2015 | Director | 85,000 | $15.02 | Sell | $1,276,700.00 | |
Nov. 11, 2015 | SVP | 45,000 | $13.52 | Sell | $608,400.00 | |
Nov. 11, 2015 | CEO | 125,000 | $13.52 | Sell | $1,690,000.00 | |
Nov. 11, 2015 | CAO | 15,000 | $13.52 | Sell | $202,800.00 | |
Oct. 28, 2015 | Director | 12,500 | $12.00 | Sell | $150,000.00 | |
Oct. 6, 2015 | CEO | 125,000 | $10.99 | Sell | $1,373,750.00 | |
Oct. 6, 2015 | SVP | 45,000 | $10.99 | Sell | $494,550.00 | |
Oct. 6, 2015 | CAO | 15,000 | $10.99 | Sell | $164,850.00 | |
Sept. 23, 2015 | CEO | 124,999 | $13.04 | Sell | $1,629,986.96 | |
Sept. 23, 2015 | SVP | 44,999 | $13.04 | Sell | $586,786.96 | |
Sept. 23, 2015 | CAO | 10,000 | $13.04 | Sell | $130,400.00 | |
Aug. 13, 2015 | SVP | 33,333 | $10.89 | Sell | $362,996.37 | |
Aug. 13, 2015 | CEO | 58,333 | $10.89 | Sell | $635,246.37 | |
July 14, 2015 | CEO | 58,334 | $11.78 | Sell | $687,174.52 | |
July 14, 2015 | SVP | 33,334 | $11.78 | Sell | $392,674.52 | |
June 29, 2015 | Director | 30,000 | $12.70 | Sell | $381,000.00 | |
June 19, 2015 | Director | 15,000 | $11.81 | Sell | $177,150.00 | |
June 15, 2015 | Director | 25,000 | $11.15 | Sell | $278,750.00 | |
Dec. 29, 2014 | Director | 29,500 | $15.34 | Sell | $452,530.00 | |
Dec. 22, 2014 | CAO | 5,000 | $15.56 | Sell | $77,800.00 | |
Dec. 1, 2014 | CEO | 350,000 | $17.01 | Sell | $5,953,500.00 | |
Dec. 1, 2014 | SVP | 120,000 | $17.02 | Sell | $2,042,400.00 | |
Nov. 25, 2014 | CEO | 600,000 | $15.25 | Sell | $9,150,000.00 | |
Nov. 24, 2014 | CEO | 132,800 | $15.02 | Sell | $1,994,656.00 | |
Nov. 24, 2014 | SVP | 10,500 | $15.04 | Sell | $157,920.00 | |
Nov. 24, 2014 | Director | 15,000 | $15.02 | Sell | $225,300.00 | |
Nov. 3, 2014 | SVP | 9,900 | $13.78 | Sell | $136,422.00 | |
Aug. 5, 2013 | Director | 12,500 | $12.41 | Sell | $155,125.00 |
Insiders are both buying and selling Nektar Therapeutics stock.
The insider traders at Nektar Therapeutics are: Howard W Robin, Gil M. Labrucherie, Jillian B. Thomsen, Robert Chess, Jonathan Zalevsky, John Nicholson, Gil M Labrucherie, Howard W. Robin, Stephen K Doberstein, Jillian B Thomsen, Lutz Lingnau, Mark Andrew Wilson, Ivan P Gergel, Maninder Hora, Jeffrey Robert Ajer, R Scott Greer, Dennis L Winger, Christopher A Kuebler, Myriam Curet, Susan Wang, Christopher A. Kuebler, Roy A Whitfield, Karin Eastham, Curet Myriam, Roy Whitfield, John Northcott, Deep Track Capital, Lp, Stephen K. Doberstein, and Katharina Otto-Bernstein
The most active insider trader at Nektar Therapeutics is Howard W Robin with 46 trades.
Howard W Robin has sold the most Nektar Therapeutics stock with a total value of $84,218,795.98.
Roy A Whitfield has bought the most Nektar Therapeutics stock with a total value of $1,256,500.00.
The most recent insider trade for Nektar Therapeutics was on May 10, 2024.
The single biggest insider buy for Nektar Therapeutics was from Roy A Whitfield with a total value of $628,250.00 on Aug. 10, 2017.
The single biggest insider sell for Nektar Therapeutics was from John Nicholson with a total value of $21,853,694.88 on March 7, 2018.